-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Modulating Metabolic Pathways to Engineer Immune Function

Program: Spotlight Sessions
Session: Immunometabolism as a Tool to Advance Cell Therapy
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Biological therapies, Translational Research, Non-Biological therapies, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Checkpoint Inhibitor, Therapies, Immunotherapy
Sunday, December 10, 2023, 4:30 PM-5:45 PM

Craig Byersdorfer, MD

UPMC, Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA

Disclosures: No relevant conflicts of interest to declare.

Previous Presentation | Next Presentation >>